CIPROFLOXACIN INJECTION SOLUTION Canada - English - Health Canada

ciprofloxacin injection solution

sterimax inc - ciprofloxacin (ciprofloxacin lactate) - solution - 0.2% - ciprofloxacin (ciprofloxacin lactate) 0.2% - quinolones

Ciprofloxacin (AFT) New Zealand - English - Medsafe (Medicines Safety Authority)

ciprofloxacin (aft)

baxter healthcare ltd - ciprofloxacin lactate 2.653 mg/ml equivalent to ciprofloxacin 2 mg/ml - solution for infusion - 0.2% w/v - active: ciprofloxacin lactate 2.653 mg/ml equivalent to ciprofloxacin 2 mg/ml excipient: hydrochloric acid lactic acid sodium chloride water for injection

Ciprofloxacine Baxter 2 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ciprofloxacine baxter 2 mg/ml inf. sol. i.v. vial

baxter deutschland gmbh - ciprofloxacin lactate 2,544 mg/ml - eq. ciprofloxacin 2 mg/ml - solution for infusion - 2 mg/ml - ciprofloxacin lactate - ciprofloxacin

Ciprofloxacine Baxter 2 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ciprofloxacine baxter 2 mg/ml inf. sol. i.v. vial

baxter deutschland gmbh - ciprofloxacin lactate 2,544 mg/ml - eq. ciprofloxacin 2 mg/ml - solution for infusion - 2 mg/ml - ciprofloxacin lactate - ciprofloxacin

Ciprofloxacine Baxter 2 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ciprofloxacine baxter 2 mg/ml inf. sol. i.v. vial

baxter deutschland gmbh - ciprofloxacin lactate 2,544 mg/ml - eq. ciprofloxacin 2 mg/ml - solution for infusion - 2 mg/ml - ciprofloxacin lactate - ciprofloxacin

Ciprofloxacine Baxter 2 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ciprofloxacine baxter 2 mg/ml inf. sol. i.v.

baxter deutschland gmbh - ciprofloxacin lactate 2,544 mg/ml - eq. ciprofloxacin 2 mg/ml - solution for infusion - 2 mg/ml - ciprofloxacin lactate 2.54 mg/ml - ciprofloxacin

Ciprofloxacine Baxter 2 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ciprofloxacine baxter 2 mg/ml inf. sol. i.v.

baxter deutschland gmbh - ciprofloxacin lactate 2,544 mg/ml - eq. ciprofloxacin 2 mg/ml - solution for infusion - 2 mg/ml - ciprofloxacin lactate 2.54 mg/ml - ciprofloxacin

Ciprofloxacine Baxter 2 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ciprofloxacine baxter 2 mg/ml inf. sol. i.v.

baxter deutschland gmbh - ciprofloxacin lactate 2,544 mg/ml - eq. ciprofloxacin 2 mg/ml - solution for infusion - 2 mg/ml - ciprofloxacin lactate 2.54 mg/ml - ciprofloxacin

CIPROFLOXACIN tablet, film coated United States - English - NLM (National Library of Medicine)

ciprofloxacin tablet, film coated

actavis pharma, inc. - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 250 mg - ciprofloxacin tablets are indicated in adult patients for treatment of skin and skin structure infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, proteus vulgaris, providencia stuartii, morganella morganii, citrobacter freundii, pseudomonas aeruginosa, methicillin­susceptible staphylococcus aureus, methicillin-susceptible staphylococcus epidermidis, or streptococcus pyogenes. ciprofloxacin tablets are indicated in adult patients for treatment of bone and joint infections caused by enterobacter cloacae, serratia marcescens, or pseudomonas aeruginosa. ciprofloxacin tablets are indicated in adult patients for treatment of complicated intra-abdominal infections (used in combination with metronidazole) caused by escherichia coli, pseudomonas aeruginosa, proteus mirabilis, klebsiella pneumoniae, or bacteroides fragilis. ciprofloxacin tablets are indicated in adult patients for treatment of infectious diarrhea caused by escherichia coli (enterotoxigenic isola

CIPROFLOXACIN- ciprofloxacin hydrochloride tablet, film coated United States - English - NLM (National Library of Medicine)

ciprofloxacin- ciprofloxacin hydrochloride tablet, film coated

h.j. harkins company, inc. - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 250 mg - ciprofloxacin tablets, usp are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below. please see dosage and administration for specific recommendations. urinary tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, serratia marcescens, proteus mirabilis, providencia rettgeri, morganella morganii, citrobacter diversus, citrobacter freundii, pseudomonas aeruginosa, methicillin-susceptible staphylococcus epidermidis, staphylococcus saprophyticus, or enterococcus faecalis. acute uncomplicated cystitis in females caused by escherichia coli or staphylococcus saprophyticus. chronic bacterial prostatitis caused by escherichia coli or proteus mirabilis. lower respiratory tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, pseudomonas aeruginosa, haemophilus influenzae, haemophilus parainfluenzae, or penicillin-sus